| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2240-001
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2002-30971
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2210-0004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2002-30062
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S623-917
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2230-0069
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2002-30235 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-34 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-06 |
| filingDate |
2001-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd174e6ca60c9f581bc3692d1ecd6bf5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9452275005a5acf4b64072cee846113e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2cbdc5e45d6b887e10f0df43f6725d0c |
| publicationDate |
2002-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2002019663-A1 |
| titleOfInvention |
Method for treating diseased or damaged organs |
| abstract |
This invention is directed to a method of treating a patient with diseased or damaged organs comprising administering to said patient a bioremodelable collagen-containing material which promotes the production of structural collagen, vascularization and epithelialization by the ingrowth of patient cells, wherein the material undergoes controlled biodegradation occurring with adequate living cell replacement such that the original implanted graft is bioremodeled by the patient's living cells. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105748171-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006136047-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007203564-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007239195-A1 |
| priorityDate |
1994-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |